We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals

152 hedge funds and large institutions have $414M invested in Enanta Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 68 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

106% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 33

12% more funds holding

Funds holding: 136152 (+16)

14% less capital invested

Capital invested by funds: $483M → $414M (-$68.5M)

19% less call options, than puts

Call options by funds: $1.63M | Put options by funds: $2M

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
152
Holders Change
+16
Holders Change %
+11.76%
% of All Funds
4.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
31
Increased
68
Reduced
33
Closed
13
Calls
$1.63M
Puts
$2M
Net Calls
-$373K
Net Calls Change
+$6.9M
Name Holding Trade Value Shares
Change
Change in
Stake
BA
51
BlackRock Advisors
Delaware
$1.48M +$151K +5,407 +12%
First Trust Advisors
52
First Trust Advisors
Illinois
$1.44M +$209K +7,496 +18%
Prudential Financial
53
Prudential Financial
New Jersey
$1.43M +$511K +18,344 +60%
Asset Management One
54
Asset Management One
Japan
$1.38M
AQR Capital Management
55
AQR Capital Management
Connecticut
$1.28M -$211K -7,567 -15%
New York State Teachers Retirement System (NYSTRS)
56
New York State Teachers Retirement System (NYSTRS)
New York
$1.23M +$462K +16,600 +66%
Schroder Investment Management Group
57
Schroder Investment Management Group
United Kingdom
$1.19M -$11.1M -397,487 -90%
Susquehanna International Group
58
Susquehanna International Group
Pennsylvania
$1.1M +$260K +9,326 +33%
AA
59
ALPS Advisors
Colorado
$1.09M +$13K +466 +1%
ARTA
60
A.R.T. Advisors
New York
$1.02M +$682K +24,500 +235%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$997K +$120K +4,302 +15%
CS
62
Credit Suisse
Switzerland
$995K +$472K +16,971 +100%
GC
63
Guggenheim Capital
Illinois
$928K +$332K +11,919 +61%
VOYA Investment Management
64
VOYA Investment Management
Georgia
$896K -$153K -5,480 -15%
AllianceBernstein
65
AllianceBernstein
Tennessee
$844K +$131K +4,710 +20%
Dimensional Fund Advisors
66
Dimensional Fund Advisors
Texas
$752K +$2.78K +100 +0.4%
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$735K +$158K +5,659 +29%
SO
68
STRS Ohio
Ohio
$710K +$47.3K +1,700 +8%
CWM
69
Concert Wealth Management
California
$706K +$660K +23,701 New
TA
70
Teachers Advisors
New York
$697K
BJ
71
BlackRock Japan
Japan
$682K -$311K -11,180 -32%
PPA
72
Parametric Portfolio Associates
Washington
$672K +$157K +5,631 +33%
QIM
73
Quantitative Investment Management
Virginia
$654K +$621K +22,300 New
BCM
74
Bridgeway Capital Management
Texas
$587K
VEA
75
Virtus ETF Advisers
New York
$549K +$520K +18,689 New

ENTA Hedge Fund Activity: Q1 2016 in Review

152 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q1 2016, worth a combined $414M — down 14% from $483M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ENTA positions and 13 closed out — a net gain of 18 holders — while 68 added to existing stakes and 33 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $6.69M. The largest seller was Invesco, cutting an estimated $16.1M.

  • 152 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q1 2016, up from 136 in Q4 2015.
  • Funds reported $414M of Enanta Pharmaceuticals stock for Q1 2016, down 14% quarter-over-quarter.
  • 31 funds opened new Enanta Pharmaceuticals positions in Q1 2016 and 13 closed out, a net change of +18 holders.
  • The largest Enanta Pharmaceuticals buyer in Q1 2016 was EcoR1 Capital, an estimated $6.69M added.
  • The largest Enanta Pharmaceuticals seller in Q1 2016 was Invesco, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2016.